TNF Pharmaceuticals, Inc. (formerly MyMD Pharmaceuticals) is a clinical-stage pharmaceutical company focused on extending healthy lifespan. It is developing two therapeutic platforms: Isomyosamine, a small molecule immunometabolic regulator targeting autoimmune diseases including sarcopenia, frailty, and rheumatoid arthritis; and Supera-CBD, a synthetic CBD analog targeting epilepsy, pain, and anxiety/depression. The company also holds a 13% stake in Oravax Medical and a 2.5% royalty on Oravax net sales related to a COVID-19 vaccine candidate.
expected 2026-12-18
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-04-11 | 2024-12-31 | 0001641172-25-003814 | EDGAR | 133K words |
| 2024-04-01 | 2023-12-31 | 0001493152-24-012533 | EDGAR | 111K words |
| 2023-03-31 | 2022-12-31 | 0001493152-23-010384 | EDGAR | — |
| 2022-03-31 | 2021-12-31 | 0001493152-22-008546 | EDGAR | — |
| 2021-03-01 | 2020-12-31 | 0001493152-21-005129 | EDGAR | — |
| 2020-03-25 | 2019-12-31 | 0001493152-20-004650 | EDGAR | — |
| 2019-04-01 | 2018-12-31 | 0001493152-19-004590 | EDGAR | — |
| 2018-04-03 | 2017-12-31 | 0001493152-18-004626 | EDGAR | — |
| 2017-04-11 | 2016-12-31 | 0001493152-17-003722 | EDGAR | — |
| 2016-03-30 | 2015-12-31 | 0001493152-16-008364 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-12 | 2026-06-30 | 0001493152-26-037333 | EDGAR | 47K words |
| 2025-11-19 | 2025-09-30 | 0001493152-25-024320 | EDGAR | 61K words |
| 2025-08-19 | 2025-06-30 | 0001641172-25-024859 | EDGAR | 47K words |
| 2025-05-15 | 2025-03-31 | 0001641172-25-010937 | EDGAR | 45K words |
| 2024-11-14 | 2024-09-30 | 0001493152-24-046026 | EDGAR | 54K words |
| 2024-08-19 | 2024-06-30 | 0001493152-24-032940 | EDGAR | 54K words |
| 2024-05-15 | 2024-03-31 | 0001493152-24-019976 | EDGAR | 33K words |
| 2023-11-14 | 2023-09-30 | 0001493152-23-041328 | EDGAR | 38K words |
| 2023-08-14 | 2023-06-30 | 0001493152-23-028603 | EDGAR | 36K words |
| 2023-05-15 | 2023-03-31 | 0001493152-23-017488 | EDGAR | 31K words |
| 2022-11-10 | 2022-09-30 | 0001493152-22-031423 | EDGAR | — |
| 2022-08-15 | 2022-06-30 | 0001493152-22-022611 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-09-18 | 0001493152-26-043401 | EDGAR | 1K words |
| 2026-09-11 | 0001493152-26-042394 | EDGAR | 1K words |
| 2026-03-13 | 0001493152-26-010070 | EDGAR | 1K words |
| 2026-01-23 | 0001493152-26-003440 | EDGAR | 1K words |
| 2025-12-09 | 0001493152-25-026798 | EDGAR | 1K words |
| 2025-11-14 | 0001493152-25-023596 | EDGAR | 2K words |
| 2025-10-03 | 0001493152-25-016927 | EDGAR | 8K words |
| 2025-09-26 | 0001493152-25-015774 | EDGAR | 1K words |
| 2025-09-10 | 0001641172-25-027052 | EDGAR | 1K words |
| 2025-09-02 | 0001641172-25-026167 | EDGAR | 1K words |
282 total filings indexed. 250 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001321834 |
| Ticker | QCLS |
| Exchange | Nasdaq |
| SIC | 2835: In Vitro & In Vivo Diagnostic Substances |
| Incorporated | DE |
| Website | https://www.qctechnologies.com |
| Listed | 2021-04-19 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/QCLS (~200 tokens, structured JSON with cryptographic provenance)